HCPCS Codes Similar to V2790

HCPCS Codes Similar to “V2790” Code.
Amniotic membrane for surgical reconstruction, per procedure

G0288 Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery Code added date: 20030101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON	Q4198 Genesis amniotic membrane, per square centimeter Code added date: 20190101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
Q4229 Cogenex amniotic membrane, per square centimeter Code added date: 20200701 Code effective date: 20200701 TXT \| PDF \| XML \| JSON	Q4248 Dermacyte amniotic membrane allograft, per square centimeter Code added date: 20200701 Code effective date: 20200701 TXT \| PDF \| XML \| JSON
Q4253 Zenith amniotic membrane, per square centimeter Code added date: 20211001 Code effective date: 20211001 TXT \| PDF \| XML \| JSON	Q4315 Regenelink amniotic membrane allograft, per square centimeter Code added date: 20240701 Code effective date: 20240701 TXT \| PDF \| XML \| JSON
Q4343 Dermacyte ac matrix amniotic membrane allograft, per square centimeter Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	Q4224 Human health factor 10 amniotic patch (hhf10-p), per square centimeter Code added date: 20220401 Code effective date: 20220401 TXT \| PDF \| XML \| JSON
Q4289 Revoshield + amniotic barrier, per square centimeter Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	Q4295 Amnio tri-core amniotic, per square centimeter Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0237 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON